“People Will Pay Anything for Longevity”: How Equinox is Building to Last
Plus, investment in one’s health often begets further investment. Though the efficacy and ethics of GLP-1 drugs for users who aren’t diabetic or overweight can be debated, the fact is that over 2% of Americans are on the medication — up 600% over six years, according to Fair Health. Notably,...





